Accuray (ARAY) Capital Expenditures Growth (1y) (2011 - 2026)
Accuray (ARAY) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 27.22% |
| 10 | Accuray | 41,092.55 | -38.49 Mn | 25.29 Mn | -254.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -254.44% |
| Dec 31, 2025 | 181.08% |
| Sep 30, 2025 | 27.50% |
| Mar 31, 2025 | -5.87% |
| Dec 31, 2024 | 958.56% |
| Sep 30, 2024 | 11.96% |
| Mar 31, 2024 | -31.51% |
| Dec 31, 2023 | -175.73% |
| Sep 30, 2023 | 410.39% |
| Mar 31, 2023 | 37.88% |
| Dec 31, 2022 | -70.24% |
| Sep 30, 2022 | -94.71% |
| Mar 31, 2022 | 132.73% |
| Dec 31, 2021 | 34.28% |
| Sep 30, 2021 | 155.89% |
| Mar 31, 2021 | 517.75% |
| Dec 31, 2020 | -52.76% |
| Sep 30, 2020 | -55.09% |
| Jun 30, 2020 | -336.09% |
| Mar 31, 2020 | -77.31% |